Product Types & Therapeutic Categories

Product-Type Compliance Gaps? How to Manage Quality Risks Across Therapeutic Categories

Identifying symptoms of compliance gaps or quality issues is crucial for manufacturers to take proactive measures. Here are common signals that may indicate potential problems:Click to read the full article.

Ophthalmic and Otic Quality Complaints? Sterility and Stability Solutions

Symptoms of quality issues in ophthalmic and otic products may manifest through various signals. These can include:Click to read the full article.

Cosmeceutical Compliance Confusion? Quality and Labeling Solutions for the Gray Zone

In the realm of cosmeceutical products, various signals may indicate compliance issues or quality lapses. Monitoring for these symptoms is crucial in safeguarding production integrity and regulatory standing.Click to read…

CCIT failure during stability pull: CAPA and sterility assurance controls

The initial signals of a CCIT failure during stability pulls may vary, but they're typically observed through anomalies during testing or unexpected quality control results. Symptoms may include:Click to read…

Fill volume variability after packaging change: batch disposition and patient risk assessment

The first step in addressing fill volume variability is to recognize the symptoms or signals that indicate a problem has occurred. Common symptoms include:Click to read the full article.

Sterility test failure during aseptic filling: FDA/EMA investigation expectations

Identifying the symptoms associated with a sterility test failure during aseptic filling is the first step in any investigation. Symptoms may arise through various signals, including:Click to read the full…

CCIT failure in ophthalmic/otic manufacturing: CAPA and sterility assurance controls

The first step in addressing a CCIT failure is to recognize the signals indicating that an issue may have occurred. Symptoms can arise in various forms, including:Click to read the…

PET failure during aseptic filling: batch disposition and patient risk assessment

Investigating PET Failure During Aseptic Filling: Batch Disposition and Patient Risk Assessment In the pharmaceutical industry, the integrity of aseptic processing is paramount, particularly in the production of ophthalmic and…

Fill volume variability in ophthalmic/otic manufacturing: batch disposition and patient risk assessment

The first step in addressing fill volume variability is understanding the symptoms or signals indicating a problem. Common signs of fill volume issues include:Click to read the full article.

CCIT failure during aseptic filling: batch disposition and patient risk assessment

Recognizing symptoms or signals of CCIT failures is the first step in investigation and remediation. Typical indicators include:Click to read the full article.

Sterility test failure after packaging change: FDA/EMA investigation expectations

When a sterility test fails after a packaging change, early detection is crucial. Key symptoms may include:Click to read the full article.

Sterility test failure in ophthalmic/otic manufacturing: CAPA and sterility assurance controls

In the context of ophthalmic and otic manufacturing, symptoms of a sterility test failure can manifest in various ways:Click to read the full article.